Pharming Group N.V. Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
Pharming Group N.V. (PHAR) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $13.77 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2026-04-02
EUR
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|
| 2020-12-31 | 7.36M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 4.45M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 3.89M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month as first filed |
|---|---|---|
| 2025-12-31 | $13.77M 20-F · filed 2026-04-02 | |
| 2024-12-31 | $11.25M 20-F · filed 2026-04-02 | |
| 2023-12-31 | $9.25M 20-F · filed 2026-04-02 | |
| 2022-12-31 | $6.39M 20-F · filed 2025-04-03 | |
| 2021-12-31 | $9.06M 20-F · filed 2024-04-04 | $9.05M 20-F · filed 2022-04-06 |
| 2020-12-31 | $8.40M 20-F · filed 2023-04-05 | |
| 2019-12-31 | $4.99M 20-F · filed 2022-04-06 |